Treatment of Cervical Cancer at Stage T2b to T4a
Clinical Scenario
This protocol applies to patients with locally advanced cervical cancer staged T2b to T4a — tumours that have extended beyond the cervix and may involve adjacent pelvic structures, but without distant metastasis. Managing this stage requires a coordinated, multi-modality approach guided by the extent of local disease.
Staging Context
Stages T2b through T4a represent a spectrum of locally advanced disease in which the tumour has grown beyond the cervix into the parametrium, pelvic wall, or adjacent organs. Definitive radiotherapy should include concomitant chemotherapy whenever possible at these stages.
Treatment Approach (Summary)
The definitive approach for this stage range involves external beam radiotherapy combined with concurrent systemic therapy, together with image-guided adaptive brachytherapy as an essential component.
For more advanced substages within this range, additional systemic agents may be incorporated into both the concurrent and maintenance phases of treatment. The complete structured regimen — including all agents, sequencing, and stage-specific considerations — is available in the full protocol.
References
- Definitive radiotherapy should include concomitant chemotherapy whenever possible.
- It is recommended to deliver external beam radiotherapy with a dose of 45 Gy/25 fractions or 46 Gy/23 fractions by use of intensity-modulated or volumetric arc technique.
- Concomitant weekly cisplatin is standard. However, weekly carboplatin or hyperthermia can be considered as an alternative option for patients not suitable for cisplatin.
- Image-guided brachytherapy is an essential component of definitive radiotherapy and should not be replaced with an external boost (photon or proton).
- Immunotherapy should be administered in combination with chemoradiotherapy and in the maintenance in stages IIIA/IIIB/IVA (International Federation of Gynecology and Obstetrics, FIGO 2014) (Tumour, lymph Nodes, Metastases (TNM): T3 and T4 M0) regardless of the nodal status.
DOI: 10.1016/j.ijgc.2025.102747
View source ↗